These observations as well as the gradation in richness and diversity changes from the pancreatic status comparisons (HC > PS-CF > PI-CF), suggest the influence of CFTR dysfunction and associated CF treatments on the gut microbiota affects the natural trajectory of microbial diversity. The gene discussed is CFTR; the disease is cystic fibrosis.